Steele Anna L, Bradfield Yasmin S, Kushner Burton J, France Thomas D, Struck Michael C, Gangnon Ronald E
Department of Ophthalmology, University of Wisconsin, Madison, USA.
J AAPOS. 2006 Feb;10(1):37-43. doi: 10.1016/j.jaapos.2005.08.003.
The efficacy of treating anisometropic amblyopia with occlusion therapy is well known. However, this form of treatment can be associated with risks. Spectacle correction alone may be a successful and underutilized form of treatment.
The records of 28 patients treated successfully for anisometropic amblyopia with glasses alone were reviewed. Age, initial visual acuity and stereoacuity, and nature of anisometropia were analyzed to assess associations with time required for resolution, final visual acuity, and stereoacuity. Incidence of amblyopia recurrence and results of subsequent treatment, including patching, were also studied.
Mean time to amblyopia resolution (interocular acuity difference <or=1 line) was 5.8 months (range 2 to 15 months). Worse best corrected initial visual acuity was associated with longer time to resolution (Spearman's rho = 0.37, P = 0.05), while age, initial stereoacuity, amount, and type of anisometropia were not (P = 0.43, 0.68, 0.26, 0.47, respectively). None of the astigmatic or myopic patients achieved visual acuity of 20/20 in the amblyopic eye, while seven (39%) of the hyperopic patients did. This difference was significant (P = 0.03). Better initial stereoacuity predicted good final stereoacuity (P = 0.01). Only four (14%) patients developed amblyopia recurrence over an average follow-up period of 1.7 years. All were successfully treated with updated spectacles or patching.
Treatment of anisometropic amblyopia with spectacles alone can be a successful option. Patients treated with spectacles alone may experience a lower amblyopia recurrence rate than those treated with occlusion therapy.
采用遮盖疗法治疗屈光参差性弱视的疗效已广为人知。然而,这种治疗方式可能存在风险。单纯眼镜矫正可能是一种成功但未得到充分利用的治疗方式。
回顾了28例仅通过眼镜成功治疗屈光参差性弱视患者的病历。分析了年龄、初始视力和立体视锐度以及屈光参差的性质,以评估其与弱视消退所需时间、最终视力和立体视锐度之间的关联。还研究了弱视复发的发生率以及后续治疗(包括遮盖)的结果。
弱视消退(双眼视力差异≤1行)的平均时间为5.8个月(范围为2至15个月)。初始最佳矫正视力越差,消退所需时间越长(Spearman等级相关系数ρ = 0.37,P = 0.05),而年龄、初始立体视锐度、屈光参差的程度和类型则无此关联(P分别为0.43、0.68、0.26、0.47)。散光或近视患者中,弱视眼均未达到20/20的视力,而远视患者中有7例(39%)达到了。这种差异具有统计学意义(P = 0.03)。较好的初始立体视锐度预示着良好的最终立体视锐度(P = 0.01)。在平均1.7年的随访期内,只有4例(14%)患者出现弱视复发。所有患者均通过更新眼镜或遮盖成功治愈。
仅用眼镜治疗屈光参差性弱视可能是一种成功的选择。仅接受眼镜治疗的患者弱视复发率可能低于接受遮盖疗法的患者。